These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32210548)

  • 1. Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk.
    Langholm LL; Rønnow SR; Sand JMB; Leeming DJ; Tal-Singer R; Miller BE; Vestbo J; Karsdal MA; Manon-Jensen T
    Int J Chron Obstruct Pulmon Dis; 2020; 15():543-552. PubMed ID: 32210548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort.
    Rønnow SR; Langholm LL; Karsdal MA; Manon-Jensen T; Tal-Singer R; Miller BE; Vestbo J; Leeming DJ; Sand JMB
    Respir Res; 2020 Jul; 21(1):202. PubMed ID: 32731895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
    Polatli M; Cakir A; Cildag O; Bolaman AZ; Yenisey C; Yenicerioglu Y
    J Thromb Thrombolysis; 2008 Oct; 26(2):97-102. PubMed ID: 17622488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study.
    Sand JM; Leeming DJ; Byrjalsen I; Bihlet AR; Lange P; Tal-Singer R; Miller BE; Karsdal MA; Vestbo J
    Respir Res; 2016 Oct; 17(1):125. PubMed ID: 27716343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of Prothrombotic State and Risk Assessment of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease.
    Jin Y; Zhu K; Wu S; He S; Cao C
    Int J Chron Obstruct Pulmon Dis; 2024; 19():2273-2283. PubMed ID: 39416877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD.
    Ubhi BK; Cheng KK; Dong J; Janowitz T; Jodrell D; Tal-Singer R; MacNee W; Lomas DA; Riley JH; Griffin JL; Connor SC
    Mol Biosyst; 2012 Oct; 8(12):3125-33. PubMed ID: 23051772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis.
    Langholm LL; Manon-Jensen T; Karsdal MA; Bendtsen F; Leeming DJ; Møller S
    Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1040-1048. PubMed ID: 30768435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort.
    Rønnow SR; Sand JMB; Langholm LL; Manon-Jensen T; Karsdal MA; Tal-Singer R; Miller BE; Vestbo J; Leeming DJ
    Respir Res; 2019 Apr; 20(1):63. PubMed ID: 30935391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients.
    Polosa R; Malerba M; Cacciola RR; Morjaria JB; Maugeri C; Prosperini G; Gullo R; Spicuzza L; Radaeli A; Di Maria GU
    Intern Emerg Med; 2013 Oct; 8(7):567-74. PubMed ID: 21660493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Serum Fractalkine/CX3CL1 in Patients with Chronic Obstructive Pulmonary Disease: Relationship with Emphysema Severity and Frequent Exacerbation.
    Hao W; Li M; Zhang C; Zhang Y; Xue Y
    Lung; 2019 Feb; 197(1):29-35. PubMed ID: 30382361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-product of fibrinogen is elevated in emphysematous chronic obstructive pulmonary disease and is predictive of mortality in the ECLIPSE cohort.
    Manon-Jensen T; Langholm LL; Rønnow SR; Karsdal MA; Tal-Singer R; Vestbo J; Leeming DJ; Miller BE; Bülow Sand JM
    Respir Med; 2019; 160():105814. PubMed ID: 31739246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of von Willebrand factor in COPD patients.
    Bártholo TP; Costa CH; Rufino R
    J Bras Pneumol; 2014; 40(4):373-9. PubMed ID: 25210959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis.
    Sabharwal AK; Bajaj SP; Ameri A; Tricomi SM; Hyers TM; Dahms TE; Taylor FB; Bajaj MS
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):758-67. PubMed ID: 7881667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.
    Bowler RP; Jacobson S; Cruickshank C; Hughes GJ; Siska C; Ory DS; Petrache I; Schaffer JE; Reisdorph N; Kechris K
    Am J Respir Crit Care Med; 2015 Feb; 191(3):275-84. PubMed ID: 25494452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood eosinophil count as a prognostic biomarker in COPD.
    Oh YM; Lee KS; Hong Y; Hwang SC; Kim JY; Kim DK; Yoo KH; Lee JH; Kim TH; Lim SY; Rhee CK; Yoon HK; Lee SY; Park YB; Jung JH; Kim WJ; Lee SD; Park JH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3589-3596. PubMed ID: 30464441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
    Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers.
    Hao W; Li M; Zhang Y; Zhang C; Wang P
    Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.
    Koo HK; Hong Y; Lim MN; Yim JJ; Kim WJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1129-37. PubMed ID: 27313452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.